Pfizer COVID vax 90% effective, lower hospitalization: Study

The Pfizer COVID-19 vaccine remains 90% effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot.

Related Keywords

United States ,Israel ,Saray Tartof ,Simone Wildes ,Kaiser Permanente ,Pfizer ,Us Centers For Disease ,Drug Administration ,Disease Control ,Kaiser Permanente Southern California Department ,Cdc Guidance ,Covid 19 Hospitalization ,Covid 19 Vaccine ,Covid 19 Vaccine Effectiveness ,Covid 19 Vaccine Study ,Pfizer Covid 19 Vaccine ,Pfizer Covid 19 Vaccine Effectiveness ,Pfizer Study ,Covid 19 Booster Shot ,Pfizer Vaccine Study ,